Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Enzyme-responsive progelator cyclic peptides for minimally invasive delivery to the heart post-myocardial infarction.

Carlini AS, Gaetani R, Braden RL, Luo C, Christman KL, Gianneschi NC.

Nat Commun. 2019 Apr 15;10(1):1735. doi: 10.1038/s41467-019-09587-y.

2.

Mechanical impact of parturition-related strains on rat pelvic striated sphincters.

Duran P, Ward S, Christman KL, Alperin M.

Neurourol Urodyn. 2019 Mar;38(3):912-919. doi: 10.1002/nau.23946. Epub 2019 Feb 19.

PMID:
30779377
3.

Multimodal imaging assessment and histologic correlation of the female rat pelvic floor muscles' anatomy.

Sheth VR, Duran P, Wong J, Shah S, Du J, Christman KL, Chang EY, Alperin M.

J Anat. 2019 Apr;234(4):543-550. doi: 10.1111/joa.12943. Epub 2019 Feb 10.

4.

Biomaterials for tissue repair.

Christman KL.

Science. 2019 Jan 25;363(6425):340-341. doi: 10.1126/science.aar2955. No abstract available.

PMID:
30679357
5.

Evaluation of different decellularization protocols on the generation of pancreas-derived hydrogels.

Gaetani R, Aouad S, Demaddalena LL, Straessle H, Dzieciatkowska M, Wortham M, Bender HR, Nguyen-Ngoc KV, Schmid-Schoenbein GW, George SC, Hughes CCW, Sander M, Hansen KC, Christman KL.

Tissue Eng Part C Methods. 2018 Nov 6. doi: 10.1089/ten.TEC.2018.0180. [Epub ahead of print]

PMID:
30398401
6.

A Bioprinted Cardiac Patch Composed of Cardiac-Specific Extracellular Matrix and Progenitor Cells for Heart Repair.

Bejleri D, Streeter BW, Nachlas ALY, Brown ME, Gaetani R, Christman KL, Davis ME.

Adv Healthc Mater. 2018 Dec;7(23):e1800672. doi: 10.1002/adhm.201800672. Epub 2018 Oct 31.

PMID:
30379414
7.

Extracellular matrix hydrogel therapies: In vivo applications and development.

Spang MT, Christman KL.

Acta Biomater. 2018 Mar 1;68:1-14. doi: 10.1016/j.actbio.2017.12.019. Epub 2017 Dec 20. Review.

8.

Enzyme-Targeted Nanoparticles for Delivery to Ischemic Skeletal Muscle.

Ungerleider JL, Kammeyer JK, Braden RL, Christman KL, Gianneschi NC.

Polym Chem. 2017 Sep 14;8(34):5212-5219. doi: 10.1039/C7PY00568G. Epub 2017 May 24.

9.

Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease.

Hernandez MJ, Christman KL.

JACC Basic Transl Sci. 2017 Apr;2(2):212-226. doi: 10.1016/j.jacbts.2016.11.008. Epub 2017 Apr 24.

10.

Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials.

Wang RM, Johnson TD, He J, Rong Z, Wong M, Nigam V, Behfar A, Xu Y, Christman KL.

Biomaterials. 2017 Jun;129:98-110. doi: 10.1016/j.biomaterials.2017.03.016. Epub 2017 Mar 11.

11.

Engineering an Injectable Muscle-Specific Microenvironment for Improved Cell Delivery Using a Nanofibrous Extracellular Matrix Hydrogel.

Rao N, Agmon G, Tierney MT, Ungerleider JL, Braden RL, Sacco A, Christman KL.

ACS Nano. 2017 Apr 25;11(4):3851-3859. doi: 10.1021/acsnano.7b00093. Epub 2017 Mar 27.

12.

Fibronectin and Cyclic Strain Improve Cardiac Progenitor Cell Regenerative Potential In Vitro.

French KM, Maxwell JT, Bhutani S, Ghosh-Choudhary S, Fierro MJ, Johnson TD, Christman KL, Taylor WR, Davis ME.

Stem Cells Int. 2016;2016:8364382. doi: 10.1155/2016/8364382. Epub 2016 Aug 16.

13.

Modulating In Vivo Degradation Rate of Injectable Extracellular Matrix Hydrogels.

Wassenaar JW, Braden RL, Osborn KG, Christman KL.

J Mater Chem B. 2016 Apr 28;4(16):2794-2802. Epub 2016 Mar 28.

14.

Controlling stem cell behavior with decellularized extracellular matrix scaffolds.

Agmon G, Christman KL.

Curr Opin Solid State Mater Sci. 2016 Aug;20(4):193-201.

15.

Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model.

Ungerleider JL, Johnson TD, Hernandez MJ, Elhag DI, Braden RL, Dzieciatkowska M, Osborn KG, Hansen KC, Mahmud E, Christman KL.

JACC Basic Transl Sci. 2016 Jan-Feb;1(1-2):32-44.

16.

Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.

Wassenaar JW, Gaetani R, Garcia JJ, Braden RL, Luo CG, Huang D, DeMaria AN, Omens JH, Christman KL.

J Am Coll Cardiol. 2016 Mar 8;67(9):1074-86. doi: 10.1016/j.jacc.2015.12.035.

17.

Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment.

Suarez SL, Muñoz A, Mitchell A, Braden RL, Luo C, Cochran JR, Almutairi A, Christman KL.

ACS Biomater Sci Eng. 2016 Feb 8;2(2):197-204. doi: 10.1021/acsbiomaterials.5b00335. Epub 2015 Dec 14.

18.

Cardiac-Derived Extracellular Matrix Enhances Cardiogenic Properties of Human Cardiac Progenitor Cells.

Gaetani R, Yin C, Srikumar N, Braden R, Doevendans PA, Sluijter JP, Christman KL.

Cell Transplant. 2016;25(9):1653-1663. Epub 2015 Nov 16.

PMID:
26572770
19.

Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction.

Nguyen MM, Carlini AS, Chien MP, Sonnenberg S, Luo C, Braden RL, Osborn KG, Li Y, Gianneschi NC, Christman KL.

Adv Mater. 2015 Oct 7;27(37):5547-52. doi: 10.1002/adma.201502003. Epub 2015 Aug 25.

20.

Intramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagation.

Suarez SL, Rane AA, Muñoz A, Wright AT, Zhang SX, Braden RL, Almutairi A, McCulloch AD, Christman KL.

Acta Biomater. 2015 Oct;26:13-22. doi: 10.1016/j.actbio.2015.08.004. Epub 2015 Aug 8.

21.

Quantification of decellularized human myocardial matrix: A comparison of six patients.

Johnson TD, Hill RC, Dzieciatkowska M, Nigam V, Behfar A, Christman KL, Hansen KC.

Proteomics Clin Appl. 2016 Jan;10(1):75-83. doi: 10.1002/prca.201500048. Epub 2015 Sep 28.

22.

Micro- and Nanoparticles for Treating Cardiovascular Disease.

Suarez S, Almutairi A, Christman KL.

Biomater Sci. 2015 Apr;3(4):564-80. doi: 10.1039/C4BM00441H.

23.

Decellularized skeletal muscle as an in vitro model for studying drug-extracellular matrix interactions.

Wassenaar JW, Boss GR, Christman KL.

Biomaterials. 2015 Sep;64:108-14. doi: 10.1016/j.biomaterials.2015.06.033. Epub 2015 Jun 20.

24.

Decellularized myocardial matrix hydrogels: In basic research and preclinical studies.

Wang RM, Christman KL.

Adv Drug Deliv Rev. 2016 Jan 15;96:77-82. doi: 10.1016/j.addr.2015.06.002. Epub 2015 Jun 6. Review.

25.

Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction.

Gaetani R, Feyen DA, Verhage V, Slaats R, Messina E, Christman KL, Giacomello A, Doevendans PA, Sluijter JP.

Biomaterials. 2015 Aug;61:339-48. doi: 10.1016/j.biomaterials.2015.05.005. Epub 2015 May 28.

PMID:
26043062
26.

Binding of Anticell Adhesive Oxime-Crosslinked PEG Hydrogels to Cardiac Tissues.

Grover GN, Garcia J, Nguyen MM, Zanotelli M, Madani MM, Christman KL.

Adv Healthc Mater. 2015 Jun 24;4(9):1327-31. doi: 10.1002/adhm.201500167. Epub 2015 May 12.

27.

Differential β3 Integrin Expression Regulates the Response of Human Lung and Cardiac Fibroblasts to Extracellular Matrix and Its Components.

Merna N, Fung KM, Wang JJ, King CR, Hansen KC, Christman KL, George SC.

Tissue Eng Part A. 2015 Aug;21(15-16):2195-205. doi: 10.1089/ten.TEA.2014.0337. Epub 2015 Jun 3.

28.

Developing injectable nanomaterials to repair the heart.

Nguyen MM, Gianneschi NC, Christman KL.

Curr Opin Biotechnol. 2015 Aug;34:225-31. doi: 10.1016/j.copbio.2015.03.016. Epub 2015 Apr 11. Review.

29.

Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle.

Ungerleider JL, Johnson TD, Rao N, Christman KL.

Methods. 2015 Aug;84:53-9. doi: 10.1016/j.ymeth.2015.03.024. Epub 2015 Apr 2.

30.

Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.

Sonnenberg SB, Rane AA, Liu CJ, Rao N, Agmon G, Suarez S, Wang R, Munoz A, Bajaj V, Zhang S, Braden R, Schup-Magoffin PJ, Kwan OL, DeMaria AN, Cochran JR, Christman KL.

Biomaterials. 2015 Mar;45:56-63. doi: 10.1016/j.biomaterials.2014.12.021. Epub 2015 Jan 13.

31.

Injectable ECM scaffolds for cardiac repair.

Johnson TD, Braden RL, Christman KL.

Methods Mol Biol. 2014;1181:109-20. doi: 10.1007/978-1-4939-1047-2_10.

32.

Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.

Ungerleider JL, Christman KL.

Stem Cells Transl Med. 2014 Sep;3(9):1090-9. doi: 10.5966/sctm.2014-0049. Epub 2014 Jul 10. Review.

33.

Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel.

Johnson TD, Dequach JA, Gaetani R, Ungerleider J, Elhag D, Nigam V, Behfar A, Christman KL.

Biomater Sci. 2014;2014:60283D.

35.

Myocardial matrix-polyethylene glycol hybrid hydrogels for tissue engineering.

Grover GN, Rao N, Christman KL.

Nanotechnology. 2014 Jan 10;25(1):014011. doi: 10.1088/0957-4484/25/1/014011. Epub 2013 Dec 11.

36.

A co-culture device with a tunable stiffness to understand combinatorial cell-cell and cell-matrix interactions.

Rao N, Grover GN, Vincent LG, Evans SC, Choi YS, Spencer KH, Hui EE, Engler AJ, Christman KL.

Integr Biol (Camb). 2013 Nov;5(11):1344-54. doi: 10.1039/c3ib40078f. Epub 2013 Sep 24.

37.

Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.

Suarez S, Grover GN, Braden RL, Christman KL, Almutairi A.

Biomacromolecules. 2013 Nov 11;14(11):3927-35. doi: 10.1021/bm401050j. Epub 2013 Oct 16.

38.

Stimulation of adipogenesis of adult adipose-derived stem cells using substrates that mimic the stiffness of adipose tissue.

Young DA, Choi YS, Engler AJ, Christman KL.

Biomaterials. 2013 Nov;34(34):8581-8. doi: 10.1016/j.biomaterials.2013.07.103. Epub 2013 Aug 15.

39.

Materials science and tissue engineering: repairing the heart.

Radisic M, Christman KL.

Mayo Clin Proc. 2013 Aug;88(8):884-98. doi: 10.1016/j.mayocp.2013.05.003. Review.

40.

In vivo response to dynamic hyaluronic acid hydrogels.

Young JL, Tuler J, Braden R, Schüp-Magoffin P, Schaefer J, Kretchmer K, Christman KL, Engler AJ.

Acta Biomater. 2013 Jul;9(7):7151-7. doi: 10.1016/j.actbio.2013.03.019. Epub 2013 Mar 21.

41.

Oxime cross-linked injectable hydrogels for catheter delivery.

Grover GN, Braden RL, Christman KL.

Adv Mater. 2013 Jun 4;25(21):2937-42. doi: 10.1002/adma.201205234. Epub 2013 Mar 12.

42.

Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Seif-Naraghi SB, Singelyn JM, Salvatore MA, Osborn KG, Wang JJ, Sampat U, Kwan OL, Strachan GM, Wong J, Schup-Magoffin PJ, Braden RL, Bartels K, DeQuach JA, Preul M, Kinsey AM, DeMaria AN, Dib N, Christman KL.

Sci Transl Med. 2013 Feb 20;5(173):173ra25. doi: 10.1126/scitranslmed.3005503. Erratum in: Sci Transl Med. 2014 Apr 23;6(233):233er2.

43.

Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction.

Johnson TD, Christman KL.

Expert Opin Drug Deliv. 2013 Jan;10(1):59-72. doi: 10.1517/17425247.2013.739156. Epub 2012 Nov 9. Review.

PMID:
23140533
44.

Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices.

Rao N, Evans S, Stewart D, Spencer KH, Sheikh F, Hui EE, Christman KL.

Biomed Microdevices. 2013 Feb;15(1):161-9. doi: 10.1007/s10544-012-9709-9.

45.

Treating the leading killer.

Christman KL.

Sci Transl Med. 2012 Aug 8;4(146):146fs26. doi: 10.1126/scitranslmed.3004565.

PMID:
22875825
46.

A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro.

French KM, Boopathy AV, DeQuach JA, Chingozha L, Lu H, Christman KL, Davis ME.

Acta Biomater. 2012 Dec;8(12):4357-64. doi: 10.1016/j.actbio.2012.07.033. Epub 2012 Jul 27.

47.

Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.

Seif-Naraghi SB, Horn D, Schup-Magoffin PJ, Christman KL.

Acta Biomater. 2012 Oct;8(10):3695-703. doi: 10.1016/j.actbio.2012.06.030. Epub 2012 Jun 28.

48.

Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model.

DeQuach JA, Lin JE, Cam C, Hu D, Salvatore MA, Sheikh F, Christman KL.

Eur Cell Mater. 2012 Jun 5;23:400-12; discussion 412.

49.

Injectable biomaterials for adipose tissue engineering.

Young DA, Christman KL.

Biomed Mater. 2012 Apr;7(2):024104. doi: 10.1088/1748-6041/7/2/024104. Epub 2012 Mar 29.

50.

Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.

Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faulk DM, Wang J, Mayle KM, Bartels K, Salvatore M, Kinsey AM, Demaria AN, Dib N, Christman KL.

J Am Coll Cardiol. 2012 Feb 21;59(8):751-63. doi: 10.1016/j.jacc.2011.10.888.

Supplemental Content

Loading ...
Support Center